BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19339069)

  • 1. The delineation of target volumes for radiotherapy of lung cancer patients.
    Vorwerk H; Beckmann G; Bremer M; Degen M; Dietl B; Fietkau R; Gsänger T; Hermann RM; Alfred Herrmann MK; Höller U; van Kampen M; Körber W; Maier B; Martin T; Metz M; Richter R; Siekmeyer B; Steder M; Wagner D; Hess CF; Weiss E; Christiansen H
    Radiother Oncol; 2009 Jun; 91(3):455-60. PubMed ID: 19339069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
    Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluation.
    Steenbakkers RJ; Duppen JC; Fitton I; Deurloo KE; Zijp L; Uitterhoeve AL; Rodrigus PT; Kramer GW; Bussink J; De Jaeger K; Belderbos JS; Hart AA; Nowak PJ; van Herk M; Rasch CR
    Radiother Oncol; 2005 Nov; 77(2):182-90. PubMed ID: 16256231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists.
    Giraud P; Elles S; Helfre S; De Rycke Y; Servois V; Carette MF; Alzieu C; Bondiau PY; Dubray B; Touboul E; Housset M; Rosenwald JC; Cosset JM
    Radiother Oncol; 2002 Jan; 62(1):27-36. PubMed ID: 11830310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis.
    Steenbakkers RJ; Duppen JC; Fitton I; Deurloo KE; Zijp LJ; Comans EF; Uitterhoeve AL; Rodrigus PT; Kramer GW; Bussink J; De Jaeger K; Belderbos JS; Nowak PJ; van Herk M; Rasch CR
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):435-48. PubMed ID: 16198064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference in target definition using three different methods to include respiratory motion in radiotherapy of lung cancer.
    Sloth Møller D; Knap MM; Nyeng TB; Khalil AA; Holt MI; Kandi M; Hoffmann L
    Acta Oncol; 2017 Nov; 56(11):1604-1609. PubMed ID: 28885090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A teaching intervention in a contouring dummy run improved target volume delineation in locally advanced non-small cell lung cancer: Reducing the interobserver variability in multicentre clinical studies.
    Schimek-Jasch T; Troost EG; Rücker G; Prokic V; Avlar M; Duncker-Rohr V; Mix M; Doll C; Grosu AL; Nestle U
    Strahlenther Onkol; 2015 Jun; 191(6):525-33. PubMed ID: 25665799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
    Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
    Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cone-beam CT-based delineation of stereotactic lung targets: the influence of image modality and target size on interobserver variability.
    Altorjai G; Fotina I; Lütgendorf-Caucig C; Stock M; Pötter R; Georg D; Dieckmann K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e265-72. PubMed ID: 21620581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
    Nestle U; Kremp S; Schaefer-Schuler A; Sebastian-Welsch C; Hellwig D; Rübe C; Kirsch CM
    J Nucl Med; 2005 Aug; 46(8):1342-8. PubMed ID: 16085592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
    Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
    Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning.
    Hong R; Halama J; Bova D; Sethi A; Emami B
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):720-6. PubMed ID: 17293230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer.
    Senan S; van Sörnsen de Koste J; Samson M; Tankink H; Jansen P; Nowak PJ; Krol AD; Schmitz P; Lagerwaard FJ
    Radiother Oncol; 1999 Dec; 53(3):247-55. PubMed ID: 10660205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter-observer variability in target delineation increases during adaptive treatment of head-and-neck and lung cancer.
    Apolle R; Appold S; Bijl HP; Blanchard P; Bussink J; Faivre-Finn C; Khalifa J; Laprie A; Lievens Y; Madani I; Ruffier A; de Ruysscher D; van Elmpt W; Troost EGC
    Acta Oncol; 2019 Oct; 58(10):1378-1385. PubMed ID: 31271079
    [No Abstract]   [Full Text] [Related]  

  • 16. (18)F-FDG PET-CT simulation for non-small-cell lung cancer: effect in patients already staged by PET-CT.
    Hanna GG; McAleese J; Carson KJ; Stewart DP; Cosgrove VP; Eakin RL; Zatari A; Lynch T; Jarritt PH; Young VA; O'Sullivan JM; Hounsell AR
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):24-30. PubMed ID: 19665324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?
    Biehl KJ; Kong FM; Dehdashti F; Jin JY; Mutic S; El Naqa I; Siegel BA; Bradley JD
    J Nucl Med; 2006 Nov; 47(11):1808-12. PubMed ID: 17079814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition of gross tumor volume in lung cancer: inter-observer variability.
    Van de Steene J; Linthout N; de Mey J; Vinh-Hung V; Claassens C; Noppen M; Bel A; Storme G
    Radiother Oncol; 2002 Jan; 62(1):37-49. PubMed ID: 11830311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC).
    Greco C; Rosenzweig K; Cascini GL; Tamburrini O
    Lung Cancer; 2007 Aug; 57(2):125-34. PubMed ID: 17478008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of Gross Tumor Volume Delineation for Stereotactic Body Radiotherapy of the Lung With Tri-
    Wee CW; An HJ; Kang HC; Kim HJ; Wu HG
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818787383. PubMed ID: 30012039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.